Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

Information Sheet
Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Author:

Oregon Health Authority, Public Health Division

Audiences:

Adolescents/Youth/Teens, American Indian or Alaska Native persons, At Risk Persons, Black or African American persons, General Public, Hispanic or Latino persons, Non-U.S.-born persons, Older Adults, Parents/Families, Persons experiencing homelessness, Persons with TB

Topic:

TB Treatment

Country of Origin:

United States


Global resources for the prevention,
management, and elimination of TB.